Consolidated Portfolio Review Corp’s Invesco Bloomberg Enhanced Fallen Angels ETF IFLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,216
Closed -$264K 294
2025
Q3
$264K Buy
14,216
+350
+3% +$6.47K 0.03% 401
2025
Q2
$256K Hold
13,866
0.04% 381
2025
Q1
$250K Buy
13,866
+1,750
+14% +$31.8K 0.04% 324
2024
Q4
$219K Buy
12,116
+517
+4% +$9.46K 0.03% 342
2024
Q3
$215K Buy
11,599
+27
+0.2% +$495 0.05% 285
2024
Q2
$208K Sell
11,572
-104
-0.9% -$1.87K 0.05% 277
2024
Q1
$212K Buy
11,676
+246
+2% +$4.44K 0.06% 258
2023
Q4
$207K Sell
11,430
-2,535
-18% -$44.2K 0.05% 278
2023
Q3
$239K Buy
13,965
+86
+0.6% +$1.5K 0.06% 273
2023
Q2
$243K Sell
13,879
-7,427
-35% -$129K 0.06% 270
2023
Q1
$373K Buy
+21,306
New +$370K 0.1% 187

Other funds holding IFLN

Consolidated Portfolio Review Corp's IFLN Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Invesco Bloomberg Enhanced Fallen Angels ETF (IFLN) in Q4 2025, closing a stake of 14,216 shares — an estimated $264K sold.

Consolidated Portfolio Review Corp first reported a position in IFLN in Q1 2023 and held it in 11 quarters. The position peaked at $373K in Q1 2023. 117 funds tracked by Wall St. Rank hold IFLN as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Invesco Bloomberg Enhanced Fallen Angels ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 14,216 Invesco Bloomberg Enhanced Fallen Angels ETF shares in Q4 2025, an estimated $264K.
  • Consolidated Portfolio Review Corp first reported a position in Invesco Bloomberg Enhanced Fallen Angels ETF in Q1 2023 and held it in 11 quarters.
  • Consolidated Portfolio Review Corp's Invesco Bloomberg Enhanced Fallen Angels ETF position peaked at $373K in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Invesco Bloomberg Enhanced Fallen Angels ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.